Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Toronto

$27,000.00

Elucidating transcriptional buffering and boosting in Rett syndrome and neurodevelopment

EF 2025-26

Résumé
Diseases can often arise when genes are turned on to the wrong levels. Such is the case in Rett syndrome (RTT), a devastating neurodevelopmental disorder caused by mutations in the MECP2 gene. Interestingly, our lab discovered that while RTT neurons produce the wrong levels of RNA, the cells partially compensate by altering RNA stability, a process called transcriptional buffering. This phenomenon also occurs during normal human neurodevelopment. However, healthy development also utilizes transcriptional boosting, where RNA production and stability work together to amplify gene signals. Crucially, RTT neurons do not perform boosting. The molecular mechanisms that increase RNA stability for buffering and boosting are unknown, representing potential targets for gene therapy. My preliminary analysis identified enrichment of RNA-binding proteins (RBPs) that interact with the RNA modification m6A in these gene sets. I hypothesize m6A acts as a tag to recruit RBPs to stabilize RNA molecules. However, RTT neurons have elevated levels of a competing tag, Inosine. I propose Inosine displaces m6A, disrupting the stabilization required for boosting. To investigate this, I will use two simultaneous transcriptome-wide sequencing approaches to map m6A and Inosine in these cell lines. By comparing Inosine sites in RTT neurons to m6A sites in controls, I will determine whether m6A is competitively depleted at these residues. By overlapping m6A sites with RBP sites, I will be able to identify candidate RBPs that function to increase RNA stability in response to transcription changes. Ultimately, this work will increase our understanding of the fundamental rules of RNA regulation and may have consequences for implementing gene therapies in RTT and other neurodevelopmental disorders.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
573264
Name
Bolter Gwyneth
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Elucidating transcriptional buffering and boosting in Rett syndrome and neurodevelopment
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Buffering; Inosine; Ipsc; Mecp2; N6-Methyladenosine (M6a); Neurodevelopment; Polyadenylation; Rett Syndrome; Rna Stability; Rna-Binding Protein (Rbp)
Abstract
Diseases can often arise when genes are turned on to the wrong levels. Such is the case in Rett syndrome (RTT), a devastating neurodevelopmental disorder caused by mutations in the MECP2 gene. Interestingly, our lab discovered that while RTT neurons produce the wrong levels of RNA, the cells partially compensate by altering RNA stability, a process called transcriptional buffering. This phenomenon also occurs during normal human neurodevelopment. However, healthy development also utilizes transcriptional boosting, where RNA production and stability work together to amplify gene signals. Crucially, RTT neurons do not perform boosting. The molecular mechanisms that increase RNA stability for buffering and boosting are unknown, representing potential targets for gene therapy. My preliminary analysis identified enrichment of RNA-binding proteins (RBPs) that interact with the RNA modification m6A in these gene sets. I hypothesize m6A acts as a tag to recruit RBPs to stabilize RNA molecules. However, RTT neurons have elevated levels of a competing tag, Inosine. I propose Inosine displaces m6A, disrupting the stabilization required for boosting. To investigate this, I will use two simultaneous transcriptome-wide sequencing approaches to map m6A and Inosine in these cell lines. By comparing Inosine sites in RTT neurons to m6A sites in controls, I will determine whether m6A is competitively depleted at these residues. By overlapping m6A sites with RBP sites, I will be able to identify candidate RBPs that function to increase RNA stability in response to transcription changes. Ultimately, this work will increase our understanding of the fundamental rules of RNA regulation and may have consequences for implementing gene therapies in RTT and other neurodevelopmental disorders.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Bolter, Gwyneth
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~